ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19)

Condition:   COVID-19 Vaccine Interventions:   Biological: Gamma Variant RBD-based ARVAC-CG vaccine;   Biological: Omicron Variant RBD-based ARVAC-CG vaccine;   Biological: Bivalent RBD-based ARVAC-CG vaccine;   Other: Placebo Sponsors:   Mónica Edith Lombardo;   Universidad Nacional de San Martín (UNSAM);   National Council of Scientific and Technical Research, Argentina;   Laboratorio Pablo Cassará S.R.L. Recruiting

Source: ClinicalTrials.gov - March 2, 2023 Category: Research Source Type: clinical trials